
Ark Invest bought more than 705,000 Rocket Lab shares worth roughly $45 million following RKLB stock's plunge from its May high.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

Ark Invest bought more than 705,000 Rocket Lab shares worth roughly $45 million following RKLB stock's plunge from its May high.

Rocket Lab stock gains on a bullish Raymond James research note. Here’s why analyst Brian Gesuale recommends owning RKLB shares.

Rocket Lab (RKLB) stock fell 39% between mid-June and September 10, while the S&P 500 gained 2.4%. The stock fell 39%—about twice as far as L3Harris Technologies, down 18.9%, and far more than Lockheed Martin, down 1.3%, and Northrop Grumman, down 5.3%—suggesting company-specific headwinds compounded broader sector softness. Yet the company just posted record revenue, and the CEO counts more than $1 billion of new contracts since Q2 2026 began. None of that changed the Neutron rocket's calendar.

Rocket Lab and AST SpaceMobile both want to disrupt SpaceX, both reported earnings the same night, and both stocks just took a beating. Only one of them fits a diversified portfolio right now.

Friday, Raymond James analyst Brian Gesuale launched coverage of Rocket Lab stock with a Buy rating and $80 price target.

Rocket Lab's stock has been hammered over the past month even as its backlog swells and a transformative acquisition looms, and that tension between near-term pain and long-term potential is exactly where the most interesting price setups tend to emerge.
Raymond James said Rocket Lab is building a vertically integrated and capital-efficient space platform, with strong revenue and backlog growth potential.

Rocket Lab Corporation (NASDAQ:RKLB) launched its 16th Electron mission of 2026 on September 11, carrying an Earth observation satellite into orbit for an undisclosed customer. The mission, named “Happily Ever Faster,” lifted off from Rocket Lab Launch Complex 1 in New Zealand at 3:28 p.
CEO Peter Beck blamed RKLB’s stock volatility on macro conditions, saying the business has improved across “every single metric.”

The reason has less to do with rockets than with what’s inside the panels.

No one can predict the future perfectly, but the stock appears to be considerably undervalued.

American Century Investments, an investment management company, released its first-quarter 2026 investor letter for the “American Century Investments Focused Dynamic Growth Fund”. The letter can be downloaded here. U.S. stocks advanced sharply with double-digit quarterly gains largely due to robust earnings, resilient economic data, and momentum in AI-related stocks. However, there was a slight pullback […]

The task force will pursue faster approvals, more spaceports, priority launch corridors and improved airspace integration.

Rocket Lab unveils IMM Apex, a new high-efficiency solar cell designed specifically for spacecraft. But does that warrant buying RKLB shares today? Let’s find out!

A multi-billion-dollar insider unlock window just opened at the newly public space giant, and the shockwave is spreading across the entire sector. Here is what the next few trading sessions will reveal about whether insiders plan to cash out or hold their ground.
Record revenue and a $2.4 billion cash position give Rocket Lab room to keep funding Neutron as investors await its first flight

Rocket Lab Corporation (RKLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Rocket Lab Corporation (NASDAQ:RKLB) shares gained 2. 4% in premarket trading on Wednesday after the space technology company introduced IMM Apex, a new germanium-free solar cell designed for satellite and other space applications.
Cathie Wood’s ARK Space Exploration & Innovation ETF (ARKX) bought 2,341 RKLB shares on Tuesday worth about $154,000.

Revenue records keep coming, and the cash pile tops $2 billion. What's still missing is a launch date.
Rocket Lab says the new cell cuts weight by 40%, delivers 31.5% efficiency, and removes the need for germanium.

Pivotal Research just slapped a price target on SpaceX that towers above where shares currently trade, and the space complex is rallying in response, but a looming supply risk could complicate the bull case before it plays out.

Rocket Lab (RKLB) trades near $64, about 57% below the high it set inside the last year, though it is still up 49.5% over twelve months against 19.7% for the S&P 500. The business did not break along the way. What changed is the wait: how long before Neutron flies, and how much cash goes out first.

Rocket Lab keeps stacking up defense contracts, but with its latest $981 million Space Force award, the real debate is whether the stock has already priced in all that success.

A presidential caption declaring the Moon American property changes no treaty, but it may be reshuffling billions in defense contracts toward a handful of space companies already sitting on record backlogs.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.